0009
Hubei Guangji Pharmaceutical Co., Ltd. (000952)
Market Closed
25 Apr, 06:57
XSHE XSHE Primary SSE ¥
5. 28
-0.05
-0.94%
¥
2.34B Market Cap
- P/E Ratio
0.24% Div Yield
3,563,920 Volume
- Eps
¥ 5.33
Previous Close Day Range
5.23 5.37
Year Range
4.63 7.85
Earnings results expected in 32 days
Summary
000952 closed Friday lower at ¥5.28, a decrease of 0.94% from Thursday's close, completing a monthly decrease of -3.12% or ¥0.17. Over the past 12 months, 000952 stock lost -13.44%.
000952 is not paying dividends to its shareholders.
The last earnings report, released on Jun 19, 2024, missed the consensus estimates by -0.15%. On average, the company has fell short of earnings expectations by -0.02%, based on the last three reports. The next scheduled earnings report is due on May 29, 2025.
Hubei Guangji Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 29, 2020.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
Want to track 000952 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
000952 Chart
Hubei Guangji Pharmaceutical Co., Ltd. (000952) FAQ
What is the stock price today?
The current price is ¥5.28.
On which exchange is it traded?
Hubei Guangji Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 000952.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 2.34B.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on May 29, 2025.
Has Hubei Guangji Pharmaceutical Co., Ltd. ever had a stock split?
Hubei Guangji Pharmaceutical Co., Ltd. had 1 splits and the recent split was on May 29, 2020.
Hubei Guangji Pharmaceutical Co., Ltd. Profile
| Drug Manufacturers - General Industry | Healthcare Sector | Mr. Shao Zhi Guo CEO | XSHE Exchange | CNE0000010R5 ISIN |
| CN Country | 1,862 Employees | - Last Dividend | 29 May 2020 Last Split | 20 Aug 1999 IPO Date |
Overview
Hubei Guangji Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical sector that emphasizes the manufacturing and sale of an extensive range of pharmaceutical essentials. Since its establishment in 1969, the company has anchored its roots in Wuxue, China, evolving into a significant player within the industry. Hubei Guangji Pharmaceutical not only caters to the domestic market but has also expanded its horizon by exporting products to around 30 countries and regions globally. This expansion underscores its commitment to delivering quality pharmaceutical products beyond its national boundaries, marking its footprint on the international stage.
Products and Services
The company's product lineup and offerings encompass a broad array of categories aimed at fulfilling various pharmaceutical and chemical needs. These include:
- Pharmaceutical Raw Materials - These are fundamental components used in the formulation of various drugs and medication, signifying the backbone of the company's product line. Hubei Guangji Pharmaceutical Co., Ltd. focuses on the production of high-quality raw materials that meet rigorous industry standards, ensuring efficacy and safety in medical treatments.
- Medicinal Feed Additives - Targeted towards the veterinary sector, these additives are designed to enhance the nutritional value of animal feed, thereby improving animal health and productivity. The company’s commitment to innovation is reflected in its development of effective and safe additives that cater to the evolving needs of animal husbandry.
- Fine Chemicals - This category includes a wide range of specialized chemicals produced with high degrees of purity for use in pharmaceutical, agrochemical, and other industrial applications. Hubei Guangji Pharmaceutical Co., Ltd. leverages its technical expertise to manufacture fine chemicals that meet specific client requirements and industry standards.
- Preparations - The company also offers a selection of formulated pharmaceutical products that are ready for consumption or use. These preparations are the result of combining various pharmaceutical raw materials and substances to create effective medication for treating a range of medical conditions.
Contact Information
Address: No. 1 Jiangdi Road, Wuxue, China, 435400
Phone: 86 71 3621 9458
Website: https://www.guangjipharm.com
2025 © Marketlog. All Rights Reserved.
